Abstract:Tool-use LLMs are increasingly asked to act on users' behalf, but existing benchmarks usually focus on profile recall, style imitation, generic tool use, or response-level personalization. We introduce UserToolBench , a benchmark for personalized decision making in tool-use LLMs. UserToolBench tests whether a model can infer latent user preferences from interaction history, recognize when clarification is needed, and produce user-aligned tool-call trajectories under incomplete information. The benchmark is built from privacy-sanitized real interaction traces and combines structured persona profiles, public API-style tool ecosystems, and long-horizon multi-turn trajectories. It includes 10 user profiles, 36 tool sets, 1,065 turns, 170 unique tools, and evaluation-focused task types covering lack-of-information, single-tool, and multi-tool settings. Experiments with strong tool-use LLMs show that current models still have difficulty with personalized delegation. Multi-tool coordination, missing-constraint inference, and long-horizon behavioral consistency remain major bottlenecks. These results suggest that personalization evaluation should move beyond asking whether outputs sound user-specific and instead ask whether LLMs make correct decisions for the users they represent.
Abstract:Stroke is an acute cerebrovascular disease, and timely diagnosis significantly improves patient survival. However, existing automated diagnosis methods suffer from fairness issues across demographic groups, potentially exacerbating healthcare disparities. In this work we propose FAST-CAD, a theoretically grounded framework that combines domain-adversarial training (DAT) with group distributionally robust optimization (Group-DRO) for fair and accurate non-contact stroke diagnosis. Our approach is built on domain adaptation and minimax fairness theory and provides convergence guarantees and fairness bounds. We curate a multimodal dataset covering 12 demographic subgroups defined by age, gender, and posture. FAST-CAD employs self-supervised encoders with adversarial domain discrimination to learn demographic-invariant representations, while Group-DRO optimizes worst-group risk to ensure robust performance across all subgroups. Extensive experiments show that our method achieves superior diagnostic performance while maintaining fairness across demographic groups, and our theoretical analysis supports the effectiveness of the unified DAT + Group-DRO framework. This work provides both practical advances and theoretical insights for fair medical AI systems.
Abstract:Alpha mining, a critical component in quantitative investment, focuses on discovering predictive signals for future asset returns in increasingly complex financial markets. However, the pervasive issue of alpha decay, where factors lose their predictive power over time, poses a significant challenge for alpha mining. Traditional methods like genetic programming face rapid alpha decay from overfitting and complexity, while approaches driven by Large Language Models (LLMs), despite their promise, often rely too heavily on existing knowledge, creating homogeneous factors that worsen crowding and accelerate decay. To address this challenge, we propose AlphaAgent, an autonomous framework that effectively integrates LLM agents with ad hoc regularizations for mining decay-resistant alpha factors. AlphaAgent employs three key mechanisms: (i) originality enforcement through a similarity measure based on abstract syntax trees (ASTs) against existing alphas, (ii) hypothesis-factor alignment via LLM-evaluated semantic consistency between market hypotheses and generated factors, and (iii) complexity control via AST-based structural constraints, preventing over-engineered constructions that are prone to overfitting. These mechanisms collectively guide the alpha generation process to balance originality, financial rationale, and adaptability to evolving market conditions, mitigating the risk of alpha decay. Extensive evaluations show that AlphaAgent outperforms traditional and LLM-based methods in mitigating alpha decay across bull and bear markets, consistently delivering significant alpha in Chinese CSI 500 and US S&P 500 markets over the past four years. Notably, AlphaAgent showcases remarkable resistance to alpha decay, elevating the potential for yielding powerful factors.